QGEN
Qiagen NV

1,402
Mkt Cap
$9.81B
Volume
1.18M
52W High
$51.88
52W Low
$37.63
PE Ratio
24.21
QGEN Fundamentals
Price
$47.20
Prev Close
$47.25
Open
$47.50
50D MA
$45.78
Beta
0.59
Avg. Volume
1.16M
EPS (Annual)
$0.4028
P/B
2.67
Rev/Employee
$343,142.06
News
all
press releases
Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Gateway Investment Advisers LLC Takes Position in Qiagen N.V. $QGEN
Gateway Investment Advisers LLC bought a new position in Qiagen N.V. (NYSE:QGEN - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·7d ago
News Placeholder
Generali Asset Management SPA SGR Increases Holdings in Qiagen N.V. $QGEN
Generali Asset Management SPA SGR lifted its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 102.8% during the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·9d ago
News Placeholder
Allspring Global Investments Holdings LLC Raises Holdings in Qiagen N.V. $QGEN
Allspring Global Investments Holdings LLC lifted its position in Qiagen N.V. (NYSE:QGEN - Free Report) by 5.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·14d ago
News Placeholder
Burney Co. Purchases Shares of 38,699 Qiagen N.V. $QGEN
Burney Co. acquired a new position in shares of Qiagen N.V. (NYSE:QGEN - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC...
MarketBeat·16d ago
News Placeholder
Qiagen (NYSE:QGEN) Shares Set to Reverse Split on Thursday, January 8th
Shares of Qiagen N.V. (NYSE:QGEN - Free Report) are set to reverse split on Thursday, January 8th. The 19-20 reverse split was recently announced. The number of shares owned by shareholders will be...
MarketBeat·18d ago
News Placeholder
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts
Qiagen N.V. (NYSE:QGEN - Get Free Report) has been given a consensus rating of "Hold" by the ten research firms that are covering the stock, Marketbeat.com reports. Eight investment analysts have...
MarketBeat·20d ago
News Placeholder
Qiagen N.V. $QGEN Shares Sold by Voya Investment Management LLC
Voya Investment Management LLC cut its holdings in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 43.7% in the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·20d ago
News Placeholder
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised shares of Qiagen from a "hold" rating to a "buy" rating in a research report on Sunday...
MarketBeat·24d ago
News Placeholder
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
INCY wins EC approval expanding Minjuvi's label, adding a new indication for relapsed or refractory follicular lymphoma after prior therapy.
Zacks·26d ago
<
1
2
...
>

Latest QGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.